Chinese expert consensus on robotic surgery for colorectal cancer (2025 edition)

Xishan Wang , Jianmin Xu , Yanbing Zhou , Hongliang Yao , Dehai Xiong , Junjun She , on behalf of Robotic Surgery Group, Colorectal Cancer Committee of Chinese Medical Doctor Association

Clinical Cancer Bulletin ›› 2026, Vol. 5 ›› Issue (1) : 2

PDF
Clinical Cancer Bulletin ›› 2026, Vol. 5 ›› Issue (1) :2 DOI: 10.1007/s44272-026-00054-6
Consensus and Guideline
other

Chinese expert consensus on robotic surgery for colorectal cancer (2025 edition)

Author information +
History +
PDF

Abstract

Robot surgery is an important trend in contemporary colorectal cancer surgical treatment. The Robotic Surgery Group, Colorectal Cancer Committee of Chinese Medical Doctor Association organized experts in relevant fields across the country to update and revise the application standards of robotic colorectal cancer surgery based on the Expert consensus on robotic surgery for colorectal cancer (2015 edition) and the revised version in 2020, in accordance with the development of robotic surgery concepts, technologies, and equipment in recent years, in order to promote the application and promotion of robotic surgery.

Cite this article

Download citation ▾
Xishan Wang, Jianmin Xu, Yanbing Zhou, Hongliang Yao, Dehai Xiong, Junjun She, on behalf of Robotic Surgery Group, Colorectal Cancer Committee of Chinese Medical Doctor Association. Chinese expert consensus on robotic surgery for colorectal cancer (2025 edition). Clinical Cancer Bulletin, 2026, 5(1): 2 DOI:10.1007/s44272-026-00054-6

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Xu JM, Tang B, Li TYet al.. Robotic colorectal cancer surgery in China: a nationwide retrospective observational study. Surg Endosc, 2021, 35(12): 6591-6603

[2]

Yao Q, Sun QN, Ren Jet al.. Comparison of robotic-assisted versus conventional laparoscopic surgery for mid–low rectal cancer: a systematic review and meta-analysis. J Cancer Res Clin Oncol, 2023, 149(16): 15207-15217

[3]

Sun YL, Xu HR, Li ZJet al.. Robotic versus laparoscopic low anterior resection for rectal cancer: a meta-analysis[J]. World J Surg Oncol, 2016, 14(1): 61

[4]

Wee IJY, Kuo LJ, Ngu JC. Urological and sexual function after robotic and laparoscopic surgery for rectal cancer: a systematic review, meta-analysis and meta-regression. Robotics Computer Surgery, 2021, 1711-8

[5]

Wu HM, Guo RK, Li HY. Short-term and long-term efficacy in robot-assisted treatment for mid and low rectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis, 2023, 39(1 7

[6]

Leitao MM, Kreaden US, Laudone Vet al.. The RECOURSE study: long-term oncologic outcomes associated with robotically assisted minimally invasive procedures for endometrial, cervical, colorectal, lung, or prostate cancer: a systematic review and meta-analysis. Ann Surg, 2023, 2773): 387-396

[7]

Feng QY, Yuan WT, Li TYet al.. Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol, 2022, 7(11): 991-1004

[8]

Feng QY, Yuan WT, Li TYet al.. Robotic vs laparoscopic surgery for middle and low rectal cancer: the REAL randomized clinical trial. JAMA, 2025, 334(2): 136

[9]

Solaini L, Bocchino A, Avanzolini Aet al.. Robotic versus laparoscopic left colectomy: a systematic review and meta-analysis. Int J Colorectal Dis, 2022, 3771497-1507

[10]

Zheng JC, Zhao S, Chen Wet al.. Comparison of robotic right colectomy and laparoscopic right colectomy: a systematic review and meta-analysis. Tech Coloproctol, 2023, 27(7): 521-535

[11]

Kim HS, Noh GT, Chung SSet al.. Long-term oncological outcomes of robotic versus laparoscopic approaches for right colon cancer: a systematic review and meta-analysis. Tech Coloproctol, 2023, 27(12): 1183-1189

[12]

Quijano Y, Nuñez-Alfonsel J, Ielpo Bet al.. Robotic versus laparoscopic surgery for rectal cancer: a comparative cost-effectiveness study. Tech Coloproctol, 2020, 24(3): 247-254

[13]

Guan X, Liu Z, Longo Aet al.. International consensus on natural orifice specimen extraction surgery (NOSES) for colorectal cancer. Gastroenterol Rep, 2019, 7(1): 24-31

[14]

Wang SH, Tang JY, Sun WPet al.. The natural orifice specimen extraction surgery compared with conventional laparoscopy for colorectal cancer: a meta-analysis of efficacy and long-term oncological outcomes. Int J Surg, 2022, 97 106196

[15]

Zhu Z, Wang KJ, Orangio GRet al.. Clinical efficacy and quality of life after transrectal natural orifice specimen extraction for the treatment of middle and upper rectal cancer. J Gastrointest Oncol, 2020, 11(2): 260-268

[16]

Zhou ZQ, Wang KJ, Du Tet al.. Transrectal natural orifice specimen extraction (NOSE) with oncological safety: a prospective and randomized trial. J Surg Res, 2020, 254: 16-22

[17]

Redati D, Li WK, Jiang YJet al.. Short-term and long-term survival outcomes for transrectal specimen extraction after laparoscopic right hemicolectomy: a propensity-score matching study. Front Oncol, 2024, 13 1252253

[18]

Feng QY, Ng SSM, Zhang ZYet al.. Comparison between robotic natural orifice specimen extraction surgery and traditional laparoscopic low anterior resection for middle and low rectal cancer: a propensity score matching analysis. J Surg Oncol, 2021, 124(4): 607-618

[19]

Hol JC, van Oostendorp SE, Tuynman JBet al.. Long-term oncological results after transanal total mesorectal excision for rectal carcinoma. Tech Coloproctology, 2019, 23(9): 903-911

[20]

Roodbeen SX, Spinelli A, Bemelman WAet al.. Local recurrence after transanal total mesorectal excision for rectal cancer: a multicenter cohort study. Ann Surg, 2021, 274(2): 359-366

[21]

Zeng ZW, Luo SL, Zhang Het al.. Transanal vs laparoscopic total mesorectal excision and 3-year disease-free survival in rectal cancer: the talar randomized clinical trial. JAMA, 2025, 333(9): 774-783

[22]

Rouanet P, Guerrieri M, Lemercier P, et al. A prospective European trial comparing laparotomy, laparoscopy, robotic-assisted, and transanal total mesorectal excision procedures in high-risk patients with rectal cancer: the RESET trial. Ann Surg, 2024. Online ahead of print.

[23]

National Comprehensive Cancer Network (NCCN). NCCN guidelines version 4.2025—colon cancer. [2025–06–25]. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1428.

[24]

National Comprehensive Cancer Network (NCCN). NCCN guidelines version 2.2025—rectal cancer. [2025–06–25]. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1461.

[25]

Vogel JD, Felder SI, Bhama ARet al.. The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of colon cancer. Dis Colon Rectum, 2022, 65(2): 148-177

[26]

Langenfeld SJ, Davis BR, Vogel JDet al.. The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of rectal cancer 2023 supplement. Dis Colon Rectum, 2024, 67(1): 18-31

[27]

Foo CC, Law WL. The learning curve of robotic-assisted low rectal resection of a novice rectal surgeon. World J Surg, 2016, 40(2): 456-462

[28]

Jiménez-Rodríguez RM, Rubio-Dorado-manzanares M, Díaz-Pavón JMet al.. Learning curve in robotic rectal cancer surgery: current state of affairs. Int J Colorectal Dis, 2016, 31(12): 1807-1815

[29]

Yamaguchi T, Kinugasa Y, Shiomi Aet al.. Learning curve for robotic-assisted surgery for rectal cancer: use of the cumulative sum method. Surg Endosc, 2015, 29(7): 1679-1685

[30]

Park EJ, Kim CW, Cho MSet al.. Multidimensional analyses of the learning curve of robotic low anterior resection for rectal cancer: 3-phase learning process comparison. Surg Endosc, 2014, 28(10): 2821-2831

[31]

Sng KK, Hara M, Shin JWet al.. The multiphasic learning curve for robot-assisted rectal surgery. Surg Endosc, 2013, 27(9): 3297-3307

[32]

Melich G, Hong YK, Kim Jet al.. Simultaneous development of laparoscopy and robotics provides acceptable perioperative outcomes and shows robotics to have a faster learning curve and to be overall faster in rectal cancer surgery: analysis of novice MIS surgeon learning curves. Surg Endosc, 2015, 29(3): 558-568

[33]

Huang YM, Huang YJ, Wei PL. Outcomes of robotic versus laparoscopic surgery for mid and low rectal cancer after neoadjuvant chemoradiation therapy and the effect of learning curve. Medicine, 2017, 96(40 e8171

[34]

Odermatt M, Ahmed J, Panteleimonitis Set al.. Prior experience in laparoscopic rectal surgery can minimise the learning curve for robotic rectal resections: a cumulative sum analysis. Surg Endosc, 2017, 3110): 4067-4076

[35]

Chinese Society of Colorectal Surgery, Chinese Society of Surgery, Chinese Medical Association, Chinese Society of Laparoscopic and Endoscopic Surgery, Chinese Society of Surgery, Chinese Medical Association. Chinese expert consensus on application of energy instruments in colorectal cancer surgery (2021 edition). Chin J Pract Surg. 2021;41(10):1090–7.

[36]

Dou RX, Zhou ZL, Wang JP. Bowel preparation before elective surgery for colorectal cancer. Chin J Gastrointest Surg, 2022, 25(7): 645-647

[37]

Hohenberger W, Weber K, Matzel Ket al.. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation—technical notes and outcome. Colorectal Dis, 2009, 11(4): 354-364

[38]

Heald RJ, Husband EM, Ryall RH. The mesorectum in rectal cancer surgery—the clue to pelvic recurrence?. J Br Surg, 1982, 69(10): 613-616

[39]

China Anti-Cancer Association, Colorectal Cancer Professional Committee, Chinese Anti⁃Cancer Association. CACA guidelines for holistic integrative management of cancer—colonic cancer. Chin J Colorectal Dis (Electron Ed). 2022;11(1):1–12.

[40]

China Anti-Cancer Association, Colorectal Cancer Professional Committee, Chinese Anti⁃Cancer Association. CACA guidelines for holistic integrative management of cancer—rectal cancer. Chin J Colorectal Dis (Electron Ed). 2022;11(2):89–103.

[41]

Wang XS. Current challenges and prospects of NOSES in China. Chin J Colorectal Dis (Electron Ed), 2018, 7(1): 2-7

[42]

Colorectal Cancer Professional Committee of the Chinese Medical Doctor AssociationColorectal Cancer Professional Committee of the China Anti-Cancer AssociationChina NOSES Alliance. Guidelines for natural orifice specimen extraction surgery in colorectal neoplasm (v 2023). Chin J Colorectal Dis (Electron Ed), 2023, 12(2): 89-99

[43]

Emile SH, Horesh N, Garoufalia Zet al.. An artificial intelligence-designed predictive calculator of conversion from minimally invasive to open colectomy in colon cancer. Update Surg, 2024, 76(4): 1321-1330

[44]

Abd El Aziz MA, Grass F, Behm KTet al.. Trends and consequences of surgical conversion in the United States. Surg Endosc, 2022, 36(1): 82-90

[45]

Bhama AR, Wafa AM, Ferraro Jet al.. Comparison of risk factors for unplanned conversion from laparoscopic and robotic to open colorectal surgery using the Michigan surgical quality collaborative (MSQC) database. J Gastrointest Surg, 2016, 20(6): 1223-1230

[46]

Milone M, Manigrasso M, Anoldo Pet al.. The role of robotic visceral surgery in patients with adhesions: a systematic review and meta-analysis. J Pers Med, 2022, 12(2 307

[47]

Jayne D, Pigazzi A, Marshall Het al.. Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial. JAMA, 2017, 31816): 1569

[48]

Professional Committee of Robotic Surgery, Colorectal Cancer Committee of Chinese Medical Doctor Association, Robotic and Laparoscopic Surgery Committee of Chinese Research Hospital Association. Chinese expert consensus on robotic surgery for colorectal cancer (2020 edition). Chin J Dig Surg, 2021, 20116-28

[49]

Natural Orifice Specimen Extraction Surgery (NOSES) Alliance China, Group of NOSES, Colorectal Cancer Professional Committee of the Chinese Medical Doctor Association, The Group of Robotic Surgery, Colorectal Cancer Professional Committee of the Chinese Medical Doctor Association, et al. Expert consensus on robotic natural orifice specimen extraction surgery for colorectal neoplasm (2025 edition). Chin J Colorectal Dis (Electron Ed). 2022;11(3):177–91.

[50]

Serin KR, Gultekin FA, Batman Bet al.. Robotic versus laparoscopic surgery for mid or low rectal cancer in male patients after neoadjuvant chemoradiation therapy: comparison of short-term outcomes. J Robot Surg, 2015, 9(3): 187-194

[51]

Zhu XM, Bai X, Wang HQet al.. Comparison of efficacy and safety between robotic-assisted versus laparoscopic surgery for locally advanced mid-low rectal cancer following neoadjuvant chemoradiotherapy: a systematic review and meta-analysis. Int J Surg, 2025, 111(1): 1154-1166

[52]

Asoglu O, Tokmak H, Bakir Bet al.. Robotic versus laparoscopic sphincter-saving total mesorectal excision for mid or low rectal cancer in male patients after neoadjuvant chemoradiation therapy: comparison of long-term outcomes. J Robot Surg, 2020, 14(3): 393-399

[53]

Liu HS, Zeng ZW, Zhang Het al.. Morbidity, mortality, and pathologic outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer short-term outcomes from a multicenter randomized controlled trial. Ann Surg, 2023, 277(1): 1-6

[54]

Atallah S, Nassif G, Polavarapu Het al.. Robotic-assisted transanal surgery for total mesorectal excision (RATS-TME): a description of a novel surgical approach with video demonstration. Tech Coloproctol, 2013, 17(4): 441-447

[55]

Ye JW, Tian Y, Wang Let al.. Short-term outcomes of robot-assisted transanal total mesorectal excision. Chin J Gastrointest Surg, 2017, 20(8): 900-903

[56]

Ye J, Shen H, Li Fet al.. Robotic-assisted transanal total mesorectal excision for rectal cancer: technique and results from a single institution. Tech Coloproctol, 2021, 25(6): 693-700

[57]

Li F, Zhang F, Tan Det al.. Robotic transanal total mesorectal excision combined with intersphincteric resection for ultra-low rectal cancer. Tech Coloproctol, 2021, 25(12): 1335-1336

[58]

Marks JH, Salem JF, Adams Pet al.. SP rTaTME: initial clinical experience with single-port robotic transanal total mesorectal excision (SP rTaTME). Tech Coloproctol, 2021, 25(6): 721-726

[59]

Kim IK, Bae JH, Lee YSet al.. Clinical feasibility and technical aspects of single port robotic transanal minimally invasive surgery (SP-rTAMIS) for rectal neoplasm. Robotics Computer Surgery, 2025, 21: e70026

[60]

Piozzi GN, Kim SH. Robotic intersphincteric resection for low rectal cancer: technical controversies and a systematic review on the perioperative, oncological, and functional outcomes. Ann Coloproctol, 2021, 37(6): 351-367

[61]

Wang XJ, Zheng ZF, Yu Qet al.. Impact of surgical approach on surgical resection quality in mid- and low rectal cancer, a bayesian network meta-analysis. Front Oncol, 2021, 11 699200

[62]

Huang SH, Chi P, Lin HMet al.. Risk factors of anal function after transabdominal intersphincteric resection for low rectal cancer. Chin J Gastrointest Surg, 2014, 17(10): 1014-1017

[63]

Kim JC, Lee JL, Bong JWet al.. Oncological and anorectal functional outcomes of robot-assisted intersphincteric resection in lower rectal cancer, particularly the extent of sphincter resection and sphincter saving. Surg Endosc, 2020, 34(5): 2082-2094

[64]

Barisic G, Markovic V, Popovic Met al.. Function after intersphincteric resection for low rectal cancer and its influence on quality of life: function after intersphincteric resection. Colorectal Dis, 2011, 13(6): 638-643

[65]

Tsukada Y, Ito M, Watanabe Ket al.. Topographic anatomy of the anal sphincter complex and levator ani muscle as it relates to intersphincteric resection for very low rectal disease. Dis Colon Rectum, 2016, 59(5): 426-433

[66]

Chi P, Wang XJ, Guan GXet al.. Discovery, anatomy and clinical significance of the mesorectal finish line of total mesorectal excision. Chin J Gastrointest Surg, 2017, 20(10): 1145-1150

[67]

Ghareeb WM, Wang XJ, Zhao XZet al.. The “terminal line”: a novel sign for the identification of distal mesorectum end during TME for rectal cancer. Gastroenterol Rep, 2022, 10: goac050

[68]

Liu SL, Suzuki T, Murray BWet al.. Robotic transanal minimally invasive surgery (TAMIS) with the newest robotic surgical platform: a multi-institutional North American experience. Surg Endosc, 2019, 33(2): 543-548

[69]

Tomassi MJ, Taller J, Yuhan Ret al.. Robotic transanal minimally invasive surgery for the excision of rectal neoplasia: clinical experience with 58 consecutive patients. Dis Colon Rectum, 2019, 62(3): 279-285

[70]

Baker EJ, Waters PS, Peacock Oet al.. Robotic transanal minimally invasive surgery–technical, oncological and patient outcomes from a single institution. Colorectal Dis, 2020, 22(10): 1422-1428

[71]

Zheng HC, Huang B, Xie XJet al.. Application value of da Vinci robotic transanal minimally invasive surgery for local resection of rectal neoplasms. Chin J Digest Surg, 2022, 21(5): 7

[72]

Huang B, Ye JW, Tian Yet al.. Da Vinci robotic-assisted transanal microsurgery for excision of rectal tumor. Chin J Colorectal Dis (Electron Ed), 2019, 86638-640

[73]

Marks JH, Kunkel E, Salem JFet al.. First clinical experience with single-port robotic transanal minimally invasive surgery: phase II trial of the initial 26 cases. Dis Colon Rectum, 2021, 64(8): 1003-1013

[74]

Luo QQ, Wang SM, Li HCet al.. Chinese expert consensus on robot-assisted pulmonary resections. Chin J Clin Thorac Cardiovasc Surg, 2020, 27(10): 1119-1126

[75]

China Anti-Cancer Association GU Society Minimally Invasive Surgery Section. Chinese expert consensus on laparoscopic partial nephrectomy and robotic assisted laparoscopic partial nephrectomy for renal neoplasms. J Urol Clin (Electron Version), 2021; 9(4):1–5.

[76]

Chang WJ, Liu TY, Ren Let al.. A trinity technique for prevention of low rectal anastomotic leakage in the robotic era. Eur J Surg Oncol, 2020, 46(10): e47-e54

Funding

Major project of National science and Technology(2024ZD0520300)

RIGHTS & PERMISSIONS

The Author(s)

PDF

4

Accesses

0

Citation

Detail

Sections
Recommended

/